WEKO3
AND
アイテム
{"_buckets": {"deposit": "c10b5d05-0bcf-47f4-856b-e3fd6c34d217"}, "_deposit": {"id": "21681", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "21681"}, "status": "published"}, "_oai": {"id": "oai:niigata-u.repo.nii.ac.jp:00021681"}, "item_7_alternative_title_1": {"attribute_name": "\u305d\u306e\u4ed6\u306e\u30bf\u30a4\u30c8\u30eb", "attribute_value_mlt": [{"subitem_alternative_title": "Essential Thrombocythemia : Clinical and Blood Coagulation Studies in Twenty Patients"}]}, "item_7_biblio_info_6": {"attribute_name": "\u66f8\u8a8c\u60c5\u5831", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "1991-01", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "1", "bibliographicPageEnd": "60", "bibliographicPageStart": "48", "bibliographicVolumeNumber": "105", "bibliographic_titles": [{"bibliographic_title": "\u65b0\u6f5f\u533b\u5b66\u4f1a\u96d1\u8a8c"}, {"bibliographic_title": "\u65b0\u6f5f\u533b\u5b66\u4f1a\u96d1\u8a8c", "bibliographic_titleLang": "en"}]}]}, "item_7_description_4": {"attribute_name": "\u6284\u9332", "attribute_value_mlt": [{"subitem_description": "Essential thrombocythemia (ET) is a myeloproliferative disorder, characterized by megakaryocytic hyperplasia in the bone marrow and persistent thrombocytosis without polycythemia vera, chronic myelogenous leukemia or idiopathic myelofibrosis. Though ET has been considerd to be a rare disease in Japan, we have experienced 20 cases in the last twelve years (1978\uff5e1990). The patients were 7 males and 13 females ranging in age from 28 to 91 years with a median age of 59. The platelet count ranged from 824\uff5e2773\u00d710^9/l (mean 1484\u00d710^9/l). Spontaneous platelet aggregation (SPA) was noted in 14 patients who had some clinical symptoms. Five SPA-negative patients were asymptomatic and demonstrated thrombocytosis during their medical examimations. As regarding therapy of essential thrombocythemia, active therapy by alkylating and antiplatelet drugs should be undertaken in SPA-positive patients, whereas SPA-negative patients have only to be administered with antiplatelet drugs.", "subitem_description_type": "Abstract"}]}, "item_7_full_name_3": {"attribute_name": "\u8457\u8005\u5225\u540d", "attribute_value_mlt": [{"nameIdentifiers": [{"nameIdentifier": "132246", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Kashiwaba, Mitsutoshi"}]}]}, "item_7_publisher_7": {"attribute_name": "\u51fa\u7248\u8005", "attribute_value_mlt": [{"subitem_publisher": "\u65b0\u6f5f\u533b\u5b66\u4f1a"}]}, "item_7_select_19": {"attribute_name": "\u8457\u8005\u7248\u30d5\u30e9\u30b0", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_7_source_id_11": {"attribute_name": "\u66f8\u8a8c\u30ec\u30b3\u30fc\u30c9ID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00182415", "subitem_source_identifier_type": "NCID"}]}, "item_7_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00290440", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "\u8457\u8005", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "\u67cf\u8449, \u5149\u5229"}], "nameIdentifiers": [{"nameIdentifier": "132245", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "\u30d5\u30a1\u30a4\u30eb\u60c5\u5831", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2019-08-16"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "105(1)_48-60.pdf", "filesize": [{"value": "3.2 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 3200000.0, "url": {"label": "105(1)_48-60.pdf", "url": "https://niigata-u.repo.nii.ac.jp/record/21681/files/105(1)_48-60.pdf"}, "version_id": "5d758778-df09-4143-9bfc-afc79517043f"}]}, "item_keyword": {"attribute_name": "\u30ad\u30fc\u30ef\u30fc\u30c9", "attribute_value_mlt": [{"subitem_subject": "essential thrombocythemia", "subitem_subject_scheme": "Other"}, {"subitem_subject": "spontaneous platelet aggregation", "subitem_subject_scheme": "Other"}, {"subitem_subject": "treatment", "subitem_subject_scheme": "Other"}, {"subitem_subject": "prognosis", "subitem_subject_scheme": "Other"}, {"subitem_subject": "\u539f\u767a\u6027\u8840\u5c0f\u677f\u8840\u75c7", "subitem_subject_scheme": "Other"}, {"subitem_subject": "\u81ea\u7136\u51dd\u96c6\u80fd", "subitem_subject_scheme": "Other"}, {"subitem_subject": "\u6cbb\u7642", "subitem_subject_scheme": "Other"}, {"subitem_subject": "\u4e88\u5f8c", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "\u8a00\u8a9e", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "\u8cc7\u6e90\u30bf\u30a4\u30d7", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "\u539f\u767a\u6027\u8840\u5c0f\u677f\u8840\u75c7(Essential Thrombocythemia) : \u81ea\u9a1320\u4f8b\u306b\u304a\u3051\u308b\u81e8\u5e8a\u7684\u304a\u3088\u3073\u51dd\u8840\u5b66\u7684\u691c\u8a0e", "item_titles": {"attribute_name": "\u30bf\u30a4\u30c8\u30eb", "attribute_value_mlt": [{"subitem_title": "\u539f\u767a\u6027\u8840\u5c0f\u677f\u8840\u75c7(Essential Thrombocythemia) : \u81ea\u9a1320\u4f8b\u306b\u304a\u3051\u308b\u81e8\u5e8a\u7684\u304a\u3088\u3073\u51dd\u8840\u5b66\u7684\u691c\u8a0e"}, {"subitem_title": "\u539f\u767a\u6027\u8840\u5c0f\u677f\u8840\u75c7(Essential Thrombocythemia) : \u81ea\u9a1320\u4f8b\u306b\u304a\u3051\u308b\u81e8\u5e8a\u7684\u304a\u3088\u3073\u51dd\u8840\u5b66\u7684\u691c\u8a0e", "subitem_title_language": "en"}]}, "item_type_id": "7", "owner": "1", "path": ["453/456", "471/537/538/1190"], "permalink_uri": "http://hdl.handle.net/10191/38557", "pubdate": {"attribute_name": "\u516c\u958b\u65e5", "attribute_value": "2016-02-22"}, "publish_date": "2016-02-22", "publish_status": "0", "recid": "21681", "relation": {}, "relation_version_is_last": true, "title": ["\u539f\u767a\u6027\u8840\u5c0f\u677f\u8840\u75c7(Essential Thrombocythemia) : \u81ea\u9a1320\u4f8b\u306b\u304a\u3051\u308b\u81e8\u5e8a\u7684\u304a\u3088\u3073\u51dd\u8840\u5b66\u7684\u691c\u8a0e"], "weko_shared_id": null}
原発性血小板血症(Essential Thrombocythemia) : 自験20例における臨床的および凝血学的検討
http://hdl.handle.net/10191/38557
b9dc4f85-e6b3-438b-8a2e-94004e8928a2
名前 / ファイル | ライセンス | アクション | |
---|---|---|---|
![]() |
|
Item type | 紀要論文 / Departmental Bulletin Paper(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2016-02-22 | |||||
タイトル | ||||||
タイトル | 原発性血小板血症(Essential Thrombocythemia) : 自験20例における臨床的および凝血学的検討 | |||||
タイトル | ||||||
言語 | en | |||||
タイトル | 原発性血小板血症(Essential Thrombocythemia) : 自験20例における臨床的および凝血学的検討 | |||||
言語 | ||||||
言語 | jpn | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | essential thrombocythemia | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | spontaneous platelet aggregation | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | treatment | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | prognosis | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 原発性血小板血症 | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 自然凝集能 | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 治療 | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 予後 | |||||
資源タイプ | ||||||
資源 | http://purl.org/coar/resource_type/c_6501 | |||||
タイプ | departmental bulletin paper | |||||
その他のタイトル | ||||||
その他のタイトル | Essential Thrombocythemia : Clinical and Blood Coagulation Studies in Twenty Patients | |||||
著者 |
柏葉, 光利
× 柏葉, 光利 |
|||||
著者別名 | ||||||
識別子 | ||||||
識別子 | 132246 | |||||
識別子Scheme | WEKO | |||||
姓名 | ||||||
姓名 | Kashiwaba, Mitsutoshi | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Essential thrombocythemia (ET) is a myeloproliferative disorder, characterized by megakaryocytic hyperplasia in the bone marrow and persistent thrombocytosis without polycythemia vera, chronic myelogenous leukemia or idiopathic myelofibrosis. Though ET has been considerd to be a rare disease in Japan, we have experienced 20 cases in the last twelve years (1978~1990). The patients were 7 males and 13 females ranging in age from 28 to 91 years with a median age of 59. The platelet count ranged from 824~2773×10^9/l (mean 1484×10^9/l). Spontaneous platelet aggregation (SPA) was noted in 14 patients who had some clinical symptoms. Five SPA-negative patients were asymptomatic and demonstrated thrombocytosis during their medical examimations. As regarding therapy of essential thrombocythemia, active therapy by alkylating and antiplatelet drugs should be undertaken in SPA-positive patients, whereas SPA-negative patients have only to be administered with antiplatelet drugs. | |||||
書誌情報 |
新潟医学会雑誌 en : 新潟医学会雑誌 巻 105, 号 1, p. 48-60, 発行日 1991-01 |
|||||
出版者 | ||||||
出版者 | 新潟医学会 | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 00290440 | |||||
書誌レコードID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AN00182415 | |||||
著者版フラグ | ||||||
値 | publisher |